Hypersensitivity reactions to vaccine constituents: a case series and review of the literature. 2012

Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NY, USA.

Vaccines are composed of immunogens, preservatives, adjuvants, antibiotics, and manufacturing by-products. Components of vaccines may rarely elicit adverse reactions in susceptible individuals, thus raising concerns regarding vaccine safety. In this report, we add to the medical literature 3 cases of cutaneous delayed-type hypersensitivity to the vaccine preservative aluminum. We provide a review of major constituents in vaccines that have elicited immediate-type or delayed-type hypersensitivity reactions and describe their clinical manifestations. We include a table of the Food and Drug Administration-approved vaccines, which lists the quantities of major components including ovalbumin (egg protein), gelatin, aluminum, neomycin, 2-phenoxyethanol, thimerosal, and formaldehyde. Our goals were to inform physicians on the variety of hypersensitivity reactions to common vaccines and to provide information on the choice of vaccines in patients with suspected hypersensitivity.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000277 Adjuvants, Pharmaceutic Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects. Adjuvant, Pharmaceutic,Adjuvant, Pharmaceutical,Adjuvants, Pharmaceutical,Pharmaceutic Adjuvant,Pharmaceutic Adjuvants,Pharmaceutical Adjuvant,Pharmaceutical Adjuvants
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
June 2021, JAMA dermatology,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
January 2024, Journal of the American Dental Association (1939),
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
December 1988, American journal of clinical oncology,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
December 2022, Biomedicines,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
January 2023, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
January 2014, The journal of allergy and clinical immunology. In practice,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
March 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
July 1995, Clinical and experimental dermatology,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
February 1995, Contact dermatitis,
Jonathan S Leventhal, and Emily M Berger, and Jeremy A Brauer, and David E Cohen
September 2021, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Copied contents to your clipboard!